Efficacy and safety of three-times-daily versus twice-daily biphasic insulin aspart 30 in patients with type 2 diabetes mellitus inadequately controlled with basal insulin combined with oral antidiabetic drugs

Type 2 diabetes mellitus (T2DM) is a progressive disorder characterised by a combination of insulin resistance and relative deficiency of first-phase insulin secretion due to declining beta-cell function [1,2]. American Diabetes Association (ADA) and Chinese Diabetes Society (CDS) guidelines recommend a glycaemic target of HbA1c
Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: Source Type: research